Comparative Single-Dose Pharmacokinetics and Safety of Gluteal and Deltoid Intramuscular Injection of Long-Acting Injectable Risperidone in Subjects With Chronic Stable Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 23 Jan 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 23 Jan 2010 Results were published in the Journal of Clinical Pharmacology.
- 18 Feb 2009 New trial record